Finance

Lists
PHARMA:KLSE
Pharmaniaga Bhd
MYR 1.18
+1.72%
(+0.020) 1D
Sep 11, 5:00:00 PM GMT+8  ·   MYR
All symbols
SymbolPriceChange% Change
Generating top insights for PHARMA...
Open
MYR 1.17
High
MYR 1.21
Low
MYR 1.16
Mkt. cap
1.55B
Avg. vol.
0.00
Volume
6.83M
Dividend
1.47%
Quarterly dividend
MYR 0.00
Ex-dividend date
Sep 14, 2026
P/E ratio
22.16
52-wk high
MYR 1.70
52-wk low
MYR 1.08
EPS
MYR 0.05
Shares outstanding
1.31B
No. of employees
4K
Open
MYR 1.17
High
MYR 1.21
Low
MYR 1.16
Mkt. cap
1.55B
Avg. vol.
0.00
Volume
6.83M
Dividend
1.47%
Quarterly dividend
MYR 0.00
Ex-dividend date
Sep 14, 2026
P/E ratio
22.16
52-wk high
MYR 1.70
52-wk low
MYR 1.08
EPS
MYR 0.05
Shares outstanding
1.31B
No. of employees
4K
Profile
Pharmaniaga Berhad is Malaysia’s largest listed integrated healthcare company, offering research and development, manufacturing, logistics, and distribution of pharmaceuticals and medical supplies. Wikipedia
About Pharmaniaga Bhd
CEOZulkarnain Md Eusope
Employees3.5K
Founded1994
Headquarters-
SectorHealth care provider
Websitepharmaniaga.com
Previous reportsAll values in MYR
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in MYR
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
1.01B
938.28M
1.18B
1.04B
Cost of goods sold
911.96M
841.28M
1.05B
939.04M
Cost of revenue
911.96M
841.28M
1.05B
939.04M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
73.17M
48.05M
73.51M
75.89M
Operating expense
73.17M
73.67M
73.51M
75.89M
Total operating expenses
985.13M
914.96M
1.12B
1.01B
Operating income
22.13M
23.32M
55.02M
26.10M
Other non operating income
482.00K
-2.18M
92.00K
107.00K
EBT including unusual items
10.36M
11.44M
46.41M
17.81M
EBT excluding unusual items
10.36M
11.18M
46.41M
17.81M
Income tax expense
2.87M
2.71M
14.22M
4.78M
Effective tax rate
27.67%
23.69%
30.64%
26.87%
Other operating expenses
-
-
-
-
Net income
7.28M
7.70M
31.47M
12.49M
Net profit margin
0.72%
0.82%
2.67%
1.20%
Earnings per share
-
-
-
-
Interest and investment income
2.39M
2.20M
1.38M
1.79M
Interest expense
-14.65M
-12.17M
-10.08M
-10.19M
Net interest expenses
-12.26M
-9.96M
-8.70M
-8.40M
Depreciation and amortization charges
-
19.12M
-
-
EBITDA
30.71M
30.81M
64.67M
32.51M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps